Page last updated: 2024-11-05

tranexamic acid and Uremia

tranexamic acid has been researched along with Uremia in 3 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Uremia: A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Downey, P2
Tagle, R1
Pereira, J2
Mezzano, D2
Muñoz, B1
Pais, E1
Cattaneo, M1
Mannucci, PM1

Reviews

1 review available for tranexamic acid and Uremia

ArticleYear
Current status of non-transfusional haemostatic agents.
    Haematologica, 1999, Volume: 84 Suppl EHA-4

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Coagulation Disorders; Blood Loss, Surg

1999

Other Studies

2 other studies available for tranexamic acid and Uremia

ArticleYear
Tranexamic acid and uremic bleeding: evidence-based treatment recommendations.
    Nature clinical practice. Nephrology, 2007, Volume: 3, Issue:6

    Topics: Antifibrinolytic Agents; Hemorrhage; Humans; Tranexamic Acid; Uremia

2007
Fast decrease of bleeding time by tranexamic acid in uremia.
    Thrombosis and haemostasis, 2000, Volume: 83, Issue:5

    Topics: Bleeding Time; Combined Modality Therapy; Drug Evaluation; Hemostatics; Humans; Renal Dialysis; Tran

2000